M. D. Raspide

P.371 Safety and efficacy findings in the first-in-human trial (FIH) of the oral splice modulator branaplam in type 1 spinal muscular atrophy (SMA): interim results

J. Praestgaard, E. Voltz, E. Bertini, 2017, Neuromuscular Disorders.